Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)
China flag China · Delayed Price · Currency is CNY
25.88
+0.83 (3.31%)
Aug 31, 2026, 3:00 PM CST

SHA:600566 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
5,7846,2057,9979,6388,9767,618
Other Revenue
14.1114.1120.3816.5119.8713
5,7986,2198,0179,6558,9967,631
Revenue Growth
-13.86%-22.43%-16.96%7.32%17.90%23.77%
Cost of Revenue
1,1191,3091,6661,7841,5371,277
Gross Profit
4,6804,9096,3507,8717,4596,354
Selling, General & Admin
2,3482,5593,3874,3794,4774,031
Research & Development
404.38385.1444.78464.4553.3523.44
Other Operating Expenses
90.26105.98114.37146.24138.81120.9
Operating Expenses
2,8473,0553,9244,9875,2054,683
Operating Income
1,8321,8552,4272,8842,2541,671
Interest Expense
-11.45-11.45-27.27-17.58-30.41-34.9
Interest & Investment Income
322.16256.71352.77357.81183.21171.42
Currency Exchange Gain (Loss)
-0.01-0.01----
Other Non Operating Income (Expenses)
-6.46-0.8-1.03-0.83-1.2-0.41
EBT Excluding Unusual Items
2,1372,0992,7513,2232,4051,807
Gain (Loss) on Sale of Investments
87.7641.3199.214.6-7.32114.55
Gain (Loss) on Sale of Assets
0.130.170.20.135.220.65
Asset Writedown
-1.7-0.45-0.28-1.09-0.53-0.42
Other Unusual Items
22.1722.17127.9760.42105.0928.96
Pretax Income
2,2452,1622,9783,2972,5081,950
Income Tax Expense
410.07383.99441.54470.03336.2233.22
Earnings From Continuing Operations
1,8351,7782,5372,8272,1721,717
Minority Interest in Earnings
2.72-0.41-5.15-4.28-0.971.96
Net Income
1,8381,7782,5322,8232,1711,719
Net Income to Common
1,8381,7782,5322,8232,1711,719
Net Income Growth
-4.17%-29.77%-10.32%30.04%26.27%34.60%
Shares Outstanding (Basic)
918921917916890886
Shares Outstanding (Diluted)
918921917916908900
Shares Change
-0.21%0.43%0.08%0.91%0.91%7.82%
EPS (Basic)
2.001.932.763.082.441.94
EPS (Diluted)
2.001.932.763.082.391.91
EPS Growth
-3.96%-30.07%-10.39%28.87%25.13%24.84%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
804.541,1022,0023,1622,3771,646
Free Cash Flow Per Share
0.881.202.183.452.621.83
Dividend Per Share
1.7401.7402.0901.3000.8800.680
Dividend Growth
-16.75%-16.75%60.77%47.73%29.41%51.11%
Gross Margin
80.71%78.95%79.21%81.52%82.91%83.27%
Operating Margin
31.60%29.82%30.27%29.87%25.05%21.89%
Profit Margin
31.69%28.59%31.58%29.24%24.13%22.53%
Free Cash Flow Margin
13.88%17.73%24.97%32.76%26.42%21.57%
EBITDA
2,1352,1542,7333,1852,5611,964
EBITDA Margin
36.83%34.63%34.09%32.99%28.47%25.74%
D&A For EBITDA
302.81299.16306.7301.2307.14293.13
EBIT
1,8321,8552,4272,8842,2541,671
EBIT Margin
31.60%29.82%30.27%29.87%25.05%21.89%
Effective Tax Rate
18.27%17.76%14.83%14.26%13.41%11.96%
Revenue as Reported
6,2196,2198,0179,6558,9967,631